$RIGL
RIGEL PHARMACEUTICALS INC

2024 Q3 Form 10-Q Financial Statement

#000155837024011079 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $55.31M $36.84M
YoY Change 96.58% 37.03%
Cost Of Revenue $8.026M $2.807M
YoY Change 532.97% 161.12%
Gross Profit $47.28M $34.03M
YoY Change 75.99% 31.86%
Gross Profit Margin 85.49% 92.38%
Selling, General & Admin $27.04M $28.05M
YoY Change 8.8% 6.62%
% of Gross Profit 57.2% 82.41%
Research & Development $6.182M $5.540M
YoY Change -4.53% 16.09%
% of Gross Profit 13.08% 16.28%
Depreciation & Amortization $611.0K $613.0K
YoY Change 103.67% 107.09%
% of Gross Profit 1.29% 1.8%
Operating Expenses $33.23M $33.59M
YoY Change 6.05% 8.07%
Operating Profit $14.06M $447.0K
YoY Change -414.8% -108.49%
Interest Expense $2.060M $2.029M
YoY Change 8.48% -252.21%
% of Operating Profit 14.66% 453.91%
Other Income/Expense, Net
YoY Change
Pretax Income $12.42M -$1.030M
YoY Change -318.3% -84.39%
Income Tax
% Of Pretax Income
Net Earnings $12.42M -$1.030M
YoY Change -318.22% -84.39%
Net Earnings / Revenue 22.46% -2.8%
Basic Earnings Per Share $0.71 -$0.06
Diluted Earnings Per Share $0.70 -$0.06
COMMON SHARES
Basic Shares Outstanding 17.59M 175.4M
Diluted Shares Outstanding 17.65M 17.55M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.11M $49.10M
YoY Change -2.06% -23.7%
Cash & Equivalents $51.69M $36.05M
Short-Term Investments $9.422M $13.05M
Other Short-Term Assets $9.994M $8.658M
YoY Change 233.13% 74.31%
Inventory $4.784M $8.059M
Prepaid Expenses
Receivables $30.58M $28.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $106.5M $94.72M
YoY Change 12.04% -6.15%
LONG-TERM ASSETS
Property, Plant & Equipment $99.00K $115.0K
YoY Change -47.89% -90.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.761M $4.735M
YoY Change -3.93% 775.23%
Total Long-Term Assets $32.95M $33.69M
YoY Change 62.33% 108.37%
TOTAL ASSETS
Total Short-Term Assets $106.5M $94.72M
Total Long-Term Assets $32.95M $33.69M
Total Assets $139.4M $128.4M
YoY Change 20.89% 9.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.815M $6.130M
YoY Change -52.31% 16.98%
Accrued Expenses $21.95M $17.62M
YoY Change 11.99% -2.37%
Deferred Revenue $1.355M $1.355M
YoY Change 0.0% 0.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $54.31M $58.65M
YoY Change 12.51% 33.22%
LONG-TERM LIABILITIES
Long-Term Debt $59.76M $59.69M
YoY Change 0.1% 0.2%
Other Long-Term Liabilities $39.98M $39.98M
YoY Change 3.15% -3.91%
Total Long-Term Liabilities $39.98M $39.98M
YoY Change 3.15% -60.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.31M $58.65M
Total Long-Term Liabilities $39.98M $39.98M
Total Liabilities $154.1M $158.3M
YoY Change 4.69% 9.03%
SHAREHOLDERS EQUITY
Retained Earnings -$1.404B -$1.417B
YoY Change -0.28% 1.01%
Common Stock $1.390B $1.387B
YoY Change 0.97% 0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.64M -$29.91M
YoY Change
Total Liabilities & Shareholders Equity $139.4M $128.4M
YoY Change 20.89% 9.67%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $12.42M -$1.030M
YoY Change -318.22% -84.39%
Depreciation, Depletion And Amortization $611.0K $613.0K
YoY Change 103.67% 107.09%
Cash From Operating Activities $21.68M $302.0K
YoY Change -1694.04% -94.91%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $222.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $3.812M $11.15M
YoY Change -425.81% 275.45%
Cash From Investing Activities $3.802M $10.93M
YoY Change -424.96% 267.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.842M -752.0K
YoY Change 1031.26% 101.61%
NET CHANGE
Cash From Operating Activities 21.68M 302.0K
Cash From Investing Activities 3.802M 10.93M
Cash From Financing Activities -9.842M -752.0K
Net Change In Cash 15.64M 10.48M
YoY Change -559.97% 22.89%
FREE CASH FLOW
Cash From Operating Activities $21.68M $302.0K
Capital Expenditures $10.00K $222.0K
Free Cash Flow $21.67M $80.00K
YoY Change -1693.31% -98.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.16
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17549000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17356000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17534000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17365000
CY2024Q2 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
CY2023Q2 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
RIGEL PHARMACEUTICALS INC
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001034842
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 rigl Collaborative Arrangement Revenue Recognized
CollaborativeArrangementRevenueRecognized
20000000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29889
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3248524
dei Entity Address Address Line1
EntityAddressAddressLine1
611 Gateway Boulevard, Suite 900,
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
624-1100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
RIGL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17594977
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36053000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32786000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
13049000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
24147000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28904000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30550000
CY2024Q2 us-gaap Inventory Net
InventoryNet
8059000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5522000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8658000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6261000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
94723000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
99266000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
165000
CY2024Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
28275000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
13878000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
560000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
861000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4735000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3055000
CY2024Q2 us-gaap Assets
Assets
128408000
CY2023Q4 us-gaap Assets
Assets
117225000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6130000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7142000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6373000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8676000
CY2024Q2 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
4672000
CY2023Q4 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
3513000
CY2024Q2 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
15000000
CY2024Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
18547000
CY2023Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
15684000
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
7229000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5933000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5334000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1355000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1355000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
639000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
692000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3642000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
58649000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53267000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
285000
CY2024Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
59692000
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
52373000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39981000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39944000
CY2024Q2 us-gaap Liabilities
Liabilities
158322000
CY2023Q4 us-gaap Liabilities
Liabilities
145869000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
17000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1386905000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1378881000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1416827000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1407550000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-29914000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-28644000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128408000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117225000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36841000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26886000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66375000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52956000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2807000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1075000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4832000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2052000
CY2024Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
5540000
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
4772000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
11566000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
14861000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28047000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26306000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56496000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54035000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
36394000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
32153000
us-gaap Costs And Expenses
CostsAndExpenses
72894000
us-gaap Costs And Expenses
CostsAndExpenses
70948000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
447000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5267000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6519000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17992000
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
552000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
529000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1145000
us-gaap Investment Income Interest
InvestmentIncomeInterest
922000
CY2024Q2 us-gaap Interest Expense
InterestExpense
2029000
CY2023Q2 us-gaap Interest Expense
InterestExpense
1862000
us-gaap Interest Expense
InterestExpense
3903000
us-gaap Interest Expense
InterestExpense
3066000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1030000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6600000
us-gaap Net Income Loss
NetIncomeLoss
-9277000
us-gaap Net Income Loss
NetIncomeLoss
-20136000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.16
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17549000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17356000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17534000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17365000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1030000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6600000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9277000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20136000
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-17000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
128000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1034000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6598000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9294000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20008000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-28644000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8247000
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-13000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
89000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5144000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-31671000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1030000
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
252000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2539000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-29914000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-13616000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13536000
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
126000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2768000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24257000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6600000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
554000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2186000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-28115000
us-gaap Profit Loss
ProfitLoss
-9277000
us-gaap Profit Loss
ProfitLoss
-20136000
us-gaap Share Based Compensation
ShareBasedCompensation
7662000
us-gaap Share Based Compensation
ShareBasedCompensation
4930000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-398000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1013000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
653000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
364000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
114000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1646000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19501000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4505000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1640000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2088000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3391000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
301000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
933000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1012000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2268000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2303000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2127000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
1159000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
-1882000
rigl Revenue Reserves And Refund Liability
RevenueReservesAndRefundLiability
2863000
rigl Revenue Reserves And Refund Liability
RevenueReservesAndRefundLiability
1539000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
532000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1472000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-338000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1011000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-14000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1175000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4711000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1856000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
26950000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
27400000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15348000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
8780000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
360000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15000000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
127000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11242000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3747000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
19950000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
341000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
554000
rigl Payment Of Cost Share To Collaboration Partner
PaymentOfCostShareToCollaborationPartner
3605000
rigl Payment Of Cost Share To Collaboration Partner
PaymentOfCostShareToCollaborationPartner
1754000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3264000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18750000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3267000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
24353000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32786000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24459000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36053000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48812000
us-gaap Interest Paid Net
InterestPaidNet
3457000
us-gaap Interest Paid Net
InterestPaidNet
2485000
rigl Intangible Assets Incurred But Not Yet Paid
IntangibleAssetsIncurredButNotYetPaid
15000000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:9pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:9pt;text-indent:36pt;margin:9pt 0pt 0pt 0pt;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from these estimates.</p>
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
49100000
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4079000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3720000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4079000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3720000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36841000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26886000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66375000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52956000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
27600000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
18600000
CY2023Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
15684000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
27551000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
24688000
CY2024Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
18547000
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
12145000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
18559000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
17020000
CY2023Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
13684000
rigl Contingent Payments Under Agreement
ContingentPaymentsUnderAgreement
1300000000
CY2021Q2 rigl Collaborative Arrangement Upfront Fee Received
CollaborativeArrangementUpfrontFeeReceived
125000000.0
rigl Right To Opt Out Of Agreement Number Of Periods
RightToOptOutOfAgreementNumberOfPeriods
2
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2528000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2172000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7662000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4930000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
78232
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
650000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1412669
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2145000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4609000
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
6006000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1876000
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4368000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1508000
CY2024Q2 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
12519000
CY2023Q4 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
7993000
CY2024Q2 us-gaap Inventory Net
InventoryNet
8059000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5522000
CY2024Q2 rigl Inventory Reported As Other Assets
InventoryReportedAsOtherAssets
4460000
CY2023Q4 rigl Inventory Reported As Other Assets
InventoryReportedAsOtherAssets
2471000
CY2024Q2 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
12519000
CY2023Q4 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
7993000
CY2024Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
2200000
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
0
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
30360000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2085000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1122000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28275000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13878000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1176000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2351000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2351000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2351000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2351000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
17695000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28275000
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
49102000
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
56933000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36053000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32786000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
13049000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
24147000
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
49102000
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
56933000
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
29180000
CY2024Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
29171000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
38993000
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
39001000
rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P68D
CY2023 rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P82D
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
26
CY2024Q2 rigl Investments Credit Loss Expense
InvestmentsCreditLossExpense
0
CY2023Q4 rigl Investments Credit Loss Expense
InvestmentsCreditLossExpense
0
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
22959000
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
9000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
60000000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
60000000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
308000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
398000
CY2024Q2 rigl Debt Principal Outstanding Net Of Unamortized Debt Issuance Costs
DebtPrincipalOutstandingNetOfUnamortizedDebtIssuanceCosts
59692000
CY2023Q4 rigl Debt Principal Outstanding Net Of Unamortized Debt Issuance Costs
DebtPrincipalOutstandingNetOfUnamortizedDebtIssuanceCosts
59602000
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
7229000
CY2024Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
59692000
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
52373000
CY2024Q2 us-gaap Loans Payable
LoansPayable
59692000
CY2023Q4 us-gaap Loans Payable
LoansPayable
59602000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7500000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
30000000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
22500000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
60000000
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
us-gaap Operating Lease Cost
OperatingLeaseCost
332000
us-gaap Operating Lease Cost
OperatingLeaseCost
778000
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
28000
CY2023Q2 rigl Variable Lease Expense Net Credit
VariableLeaseExpenseNetCredit
-42000
us-gaap Variable Lease Cost
VariableLeaseCost
56000
us-gaap Variable Lease Cost
VariableLeaseCost
30000
CY2024Q2 us-gaap Lease Cost
LeaseCost
194000
CY2023Q2 us-gaap Lease Cost
LeaseCost
124000
us-gaap Lease Cost
LeaseCost
388000
us-gaap Lease Cost
LeaseCost
808000
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
184000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
178000
us-gaap Operating Lease Payments
OperatingLeasePayments
368000
us-gaap Operating Lease Payments
OperatingLeasePayments
1174000
rigl Fixed Sublease Expense
FixedSubleaseExpense
365000
rigl Variable Sublease Expense
VariableSubleaseExpense
77000
us-gaap Sublease Income
SubleaseIncome
442000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
371000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
301000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
672000

Files In Submission

Name View Source Status
0001558370-24-011079-index-headers.html Edgar Link pending
0001558370-24-011079-index.html Edgar Link pending
0001558370-24-011079.txt Edgar Link pending
0001558370-24-011079-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rigl-20240630.xsd Edgar Link pending
rigl-20240630x10q.htm Edgar Link pending
rigl-20240630x10q006.jpg Edgar Link pending
rigl-20240630xex10d1.htm Edgar Link pending
rigl-20240630xex10d2.htm Edgar Link pending
rigl-20240630xex31d1.htm Edgar Link pending
rigl-20240630xex31d2.htm Edgar Link pending
rigl-20240630xex32d1.htm Edgar Link pending
Show.js Edgar Link pending
rigl-20240630_def.xml Edgar Link unprocessable
rigl-20240630_lab.xml Edgar Link unprocessable
rigl-20240630_pre.xml Edgar Link unprocessable
rigl-20240630x10q_htm.xml Edgar Link completed
rigl-20240630_cal.xml Edgar Link unprocessable